We are live on ! Find out more
EC

Elequin Capital Portfolio holdings

AUM $1.19B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
-8.01%
1 Year Est. Return
+16.08%
3 Year Est. Return
+46.25%
5 Year Est. Return
10 Year Est. Return
AUM
$437M
AUM Growth
-$154M
Cap. Flow
-$278M
Cap. Flow %
-63.62%
Top 10 Hldgs %
85.63%
Holding
469
New
128
Increased
133
Reduced
148
Closed
42
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYBR
201
DELISTED
CyberArk
CYBR
$15K ﹤0.01%
121
-8
-6% -$1.16K
PARA
202
DELISTED
Paramount Global Class B
PARA
$15K ﹤0.01%
600
+88
+17% +$2.68K
VAC icon
203
Marriott Vacations Worldwide
VAC
$3.52B
$15K ﹤0.01%
125
+2
+2% +$281
ZD icon
204
Ziff Davis
ZD
$1.95B
$15K ﹤0.01%
199
-20
-9% -$1.66K
GH icon
205
Guardant Health
GH
$19B
$14K ﹤0.01%
335
+20
+6% +$991
HALO icon
206
Halozyme
HALO
$9.9B
$14K ﹤0.01%
315
+89
+39% +$3.85K
PSN icon
207
Parsons
PSN
$6.64B
$14K ﹤0.01%
338
+67
+25% +$2.57K
SIRI icon
208
SiriusXM
SIRI
$10.7B
$14K ﹤0.01%
221
-36
-14% -$2.24K
VOYA icon
209
Voya Financial
VOYA
$9.07B
$14K ﹤0.01%
238
-58
-20% -$3.73K
IDCC icon
210
InterDigital
IDCC
$6.72B
$13K ﹤0.01%
212
+80
+61% +$4.91K
LRN icon
211
Stride
LRN
$4.08B
$13K ﹤0.01%
311
+41
+15% +$1.52K
NOVA
212
DELISTED
Sunnova Energy
NOVA
$13K ﹤0.01%
686
+54
+9% +$1.03K
RPD icon
213
Rapid7
RPD
$642M
$13K ﹤0.01%
194
-31
-14% -$2.56K
TYL icon
214
Tyler Technologies
TYL
$13.7B
$13K ﹤0.01%
40
+3
+8% +$1.1K
ELAN icon
215
Elanco Animal Health
ELAN
$12.7B
$12K ﹤0.01%
600
+195
+48% +$4.62K
IART icon
216
Integra LifeSciences
IART
$1.54B
$12K ﹤0.01%
221
-57
-21% -$3.42K
PCRX icon
217
Pacira BioSciences
PCRX
$1.05B
$12K ﹤0.01%
212
-23
-10% -$1.51K
PRGS icon
218
Progress Software
PRGS
$1.66B
$12K ﹤0.01%
263
+53
+25% +$2.52K
OPA
219
DELISTED
Magnum Opus Acquisition Limited
OPA
$12K ﹤0.01%
+1,200
New +$11.8K
ICPT
220
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12K ﹤0.01%
900
+23
+3% +$368
COUP
221
DELISTED
Coupa Software Incorporated
COUP
$12K ﹤0.01%
209
-11
-5% -$848
ZEN
222
DELISTED
ZENDESK INC
ZEN
$12K ﹤0.01%
158
-221
-58% -$21.8K
ASND icon
223
Ascendis Pharma A/S
ASND
$16.7B
$11K ﹤0.01%
113
+94
+495% +$8.86K
DOCN icon
224
DigitalOcean
DOCN
$13.2B
$11K ﹤0.01%
260
+44
+20% +$1.96K
EYE icon
225
National Vision
EYE
$1.75B
$11K ﹤0.01%
391
-171
-30% -$5.63K

Similar funds

Elequin Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Elequin Capital held 469 positions worth $437M, down 26% from $590M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Elequin Capital withdrew a net $278M in Q2 2022, closing 42 positions and reducing 148 holdings. Its most notable exit was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, an estimated $453M position sold in full.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 0.03% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Elequin Capital opened a new position in Austerlitz Acquisition Corporation II worth $2.29M.

  • Elequin Capital's largest Q2 2022 buy was Austerlitz Acquisition Corporation II: 235,000 shares worth $2.29M.
  • Elequin Capital added most to Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2022, an estimated $164M increase.
  • Elequin Capital's biggest Q2 2022 reduction was Aptiv, cutting an estimated $1.04M.
  • Elequin Capital fully exited Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A in Q2 2022, selling an estimated $453M.
  • Elequin Capital's ten largest holdings make up 86% of its $437M portfolio in Q2 2022.
  • Elequin Capital opened 128 new positions and closed 42 in Q2 2022.
  • Elequin Capital's portfolio value fell 26% quarter-over-quarter to $437M.

Based on Elequin Capital's 13F filing for Q2 2022, filed 11 Aug 2022.